Can Marvell Hold Its $276B Valuation After Jensen Huang’s Endorsement?

NEW YORK — One sentence from Jensen Huang added roughly $55 billion to Marvell Technology’s market capitalization in a single session — and the question traders are asking this weekend is whether the company can actually grow into the valuation that sentence created.

The Business Behind the Billion-Dollar Soundbite

Marvell Technology designs semiconductors for data center networking, storage, and carrier infrastructure — the unglamorous plumbing that makes AI compute clusters actually function. Its custom ASIC business, which builds application-specific chips for hyperscaler clients, has become the fastest-growing segment in the portfolio and the direct reason Huang singled the company out at Computex 2026.

The company’s competitive position is genuinely differentiated. While Broadcom dominates the custom ASIC space for the largest hyperscalers, Marvell has carved out meaningful share with its Octeon and Teralynx product lines, targeting networking and connectivity within AI data centers. Data center revenue reached $1.833 billion in Q1 FY2027, up 27% year-on-year, and now represents 76% of total company revenue. That concentration is a feature when AI capex is expanding; it becomes a risk if any single hyperscaler pauses its build-out.

The company entered fiscal 2027 after delivering record fiscal 2026 revenue of $8.195 billion, a 42% year-on-year increase. That was not a one-quarter accident — it reflected a deliberate pivot away from legacy storage and networking toward custom silicon for AI workloads that CEO Matt Murphy telegraphed two years ago. The execution on that pivot is what gives the bull case its foundation. Whether the foundation can support a $276 billion market cap is a separate conversation.

Data Visual

Marvell Quarterly Revenue Growth YoY — Q1 FY2026 Through Q1 FY2027

Shows the acceleration in Marvell’s year-on-year revenue growth rate as AI data center demand ramped, giving traders a baseline for whether the FY2027 guidance of ~$11.5B is achievable.

Values in %

The Numbers — Where the Story Gets Complicated

Q1 FY2027 net revenue of $2.418 billion came in $18 million above the midpoint of management’s own guidance — a solid beat, but not the kind of blowout that justifies a 25% single-session move on its own. The Huang endorsement did the heavy lifting there. Non-GAAP diluted EPS of $0.80 for the quarter translated to an annualized non-GAAP earnings run rate that still leaves the stock trading at a forward P/E of 69.82x on next year’s estimates.

The GAAP picture is considerably less flattering than the non-GAAP headline. GAAP net income for Q1 FY2027 was just $34.5 million, or $0.04 per diluted share, against $718 million in non-GAAP net income. The gap is driven primarily by stock-based compensation and amortization of acquired intangibles — legitimate adjustments in tech accounting, but adjustments that represent real economic costs to shareholders nonetheless.

Management’s guidance for Q2 FY2027 calls for non-GAAP EPS of $0.93 plus or minus $0.05, with GAAP EPS of $0.37 plus or minus $0.05. The full-year FY2027 revenue outlook was raised to approximately $11.5 billion, implying roughly 40% year-on-year growth. FY2028 guidance of approximately $16.5 billion implies another 45% increase. Those are extraordinary numbers. The market has largely believed them — but Broadcom’s recent guidance stumble showed how quickly sentiment can turn when hyperscaler ordering patterns shift.

For context, the trailing P/E of 109.30x compares to a semiconductor sector median closer to 30-35x. The EV/EBITDA of 102.60x is roughly three times what you would pay for Broadcom on the same metric. That premium is the market pricing in Marvell’s growth trajectory relative to a larger, slower-moving competitor — which is defensible as long as the growth actually materializes.

What the Tape Told Us This Week

The week’s price action told two contradictory stories simultaneously. The Computex surge on June 2 pushed MRVL to within striking distance of its 52-week high of $324.20. Then the macro environment reasserted itself. Strong payrolls data, a skeptical institutional AI report, and a secondary offering from Meta combined to drag the broader semiconductor complex lower June 4-5. Marvell lost 8% in that two-day stretch — more than Broadcom’s 3.8% decline, less than AMD’s 6.3%, and in line with Micron’s 6.3% drop.

The elevated volume on June 5 — 65.18 million shares traded against an average of 57.28 million — suggests the pullback involved meaningful institutional repositioning, not just retail selling into the headline. That is worth tracking. When volume spikes on a down day after a major catalyst, it often means early buyers who caught the move are distributing into the enthusiasm of later entrants. The macro headwinds that hit the broader AI trade this week have not resolved — the payrolls beat that spooked markets Friday is still on the table as a Fed policy variable, and the debate over whether rate cut expectations need to be repriced lower could keep pressure on high-multiple names through the summer.

Data Visual

MRVL Analyst Price Target Range vs. Current Price — June 2026

Plots the spread between the lowest analyst target, consensus average, current price, and top targets to show how much of the bull case is already priced in.

Values in $

What the Analyst Community Is Actually Saying

The consensus from 44 analysts polled by S&P Global is a Strong Buy, with 50% of the coverage universe at Strong Buy and 36% at Buy. Not a single analyst carries a Sell or Strong Sell rating. That near-unanimity is itself a data point — it reflects extraordinary confidence in the AI infrastructure thesis, but it also means any negative surprise lands in a market with very few natural skeptics positioned to absorb it.

Here is the number that deserves more attention than it is getting: the consensus average price target of $233.14 sits approximately 11% below where the stock is currently trading. The median target of $230 is even further below. That means the collective wisdom of the analyst community, after all the upgrades and target raises this week, still implies the stock is overvalued at current levels. Stifel’s $321 target is the most aggressive, and even that is only 22% above Friday’s close — a modest premium for a stock priced for perfection on a multi-year growth story.

The target range from $110 at the low end to $300 at the high end represents an 85% spread — unusually wide for a mega-cap stock with this much analyst coverage. That spread reflects genuine disagreement about how durable the AI capex cycle is and how much of Marvell’s custom ASIC revenue is locked in versus discretionary. If the macro backdrop shifts and AI capex spending slows, the bears at $110 will look prescient in a way that feels implausible today.

The Levels and Catalysts That Will Decide the Next Move

Marvell’s next scheduled earnings report — Q2 FY2027 — is the most important near-term event on the calendar. Management guided to non-GAAP EPS of $0.93 and revenue in a range consistent with the $11.5 billion full-year target. If the company delivers a clean beat and raises again, the Computex narrative gets fundamental validation and the stock has a credible path toward Stifel’s $321 target. If revenue comes in at the low end of guidance or any hyperscaler order softness appears in the commentary, a stock trading at 69x forward earnings has a long way to fall.

Between now and that print, the macro environment matters. The payrolls data that rattled tech this week raises real questions about the Fed’s next move, and any repricing of rate cut expectations will disproportionately hit high-duration growth stocks like MRVL. Watch the 10-year Treasury yield — a sustained move above 4.5% tends to compress the multiples that justify this kind of valuation.

Marvell Technology is a company with a genuine, differentiated AI infrastructure franchise backed by accelerating revenue and a management team that has executed on a difficult strategic pivot. None of that is in question. What is in question is whether $263 per share — 109 times trailing earnings, 167 times free cash flow — adequately compensates investors for the risks of execution, competition, and macro deterioration that all remain live. Jensen Huang’s endorsement was meaningful. It was not a financial forecast. The next quarterly earnings report will be the first real test of whether the trillion-dollar thesis has numbers behind it or just momentum.